About this trial
This study is a randomized controlled trial among 144 internally displaced people to determine the feasibility, acceptability, and preliminary effectiveness of a single-session Acceptance of Commitment Therapy (ACT) group therapy on preventing or reducing substance use behaviors.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age 18 or over
Have been displaced at least once due to Anti-Terrorist Operation (ATO) or full-scale invasion since 2014
Self-reported use of at least one substance other than alcohol and tobacco within the past 3 months
Ability to provide informed consent and speak Ukrainian or Russian
Disqualifiers
Self-reported diagnosis of a substance use disorder
Inability to provide informed consent
Trial design
Parallel
Treatments tested in this trial
Acceptance and Commitment Therapy
BehavioralThe ACT group intervention will involve a mixture of didactic instruction, discussion, and experiential activities. ACT will help internally displaced persons to manage stress and prevent or reduce substance use behaviors, ultimately mitigating the onset of substance use disorders.
Attention Control
BehavioralUsual care will be minimally enhanced by providing participants with an educational information session that provides information on health promotion.
Treatment groups
Trial outcomes
Primary outcomes
Feasibility of the ACT Intervention
Feasibility will be assessed using the 14-item feasibility subscales of the Applied Mental Health Research Group Implementation Measure (AMHR-IM). Each item is rated on a 4-point scale where "0" means "not at all" and "3" means "a lot". The overall Feasibility score is calculated as the mean (average) across all 14 completed items, where higher scores (closer to 3) reflect a higher level of perceived feasibility of the intervention.
Acceptability of the ACT Intervention
Acceptability will be assessed using the 17-item acceptability subscales of the Applied Mental Health Research Group Implementation Measure (AMHR-IM). Each item is rated on a 4-point Likert scale where "0" means "not at all" and "3" means "a lot". The overall Acceptability score is calculated as the mean (average) across all 17 completed items, where higher scores (closer to 3) reflect a higher level of perceived acceptability of the intervention.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Boston Medical Center
Lead sponsor
National Institute on Drug Abuse (NIDA)
Collaborator
This trial is not recruiting at the moment. You can still explore other options: